Basics Nurix Therapeutics, Inc. IPO Date: July 24, 2020 Sector: Healthcare Industry: Biotech Market Cap: $804.29M Activated in VL: True Average Daily Range Avg Daily Range: $0.73 | 3.59% Avg Daily Range (30 D): $0.46 | 4.08% Avg Daily Range (90 D): $0.44 | 2.94% Institutional Daily Volume Avg Daily Volume: .42M Avg Daily Volume (30 D): 1.01M Avg Daily Volume (90 D): .72M Trade Size Avg Trade Size (Sh.): 71 Avg Trade Size (Sh.) (30 D): 74 Avg Trade Size (Sh.) (90 D): 62 Institutional Trades Total Inst.Trades: 1,544 Avg Inst. Trade: $2.05M Avg Inst. Trade (30 D): $1.78M Avg Inst. Trade (90 D): $1.9M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.91M Avg Closing Trade (30 D): $1.89M Avg Closing Trade (90 D): $2.34M Avg Closing Volume: 104.82K         News Apr 8, 2025 @ 8:00 PM Nurix Therapeutics Reports First Quarter 2025 Fina... Source: Nurix Therapeutics, Inc. Mar 14, 2025 @ 8:00 PM Nurix Therapeutics Reports Inducement Grants Under... Source: Globe Newswire Feb 4, 2025 @ 12:00 PM Nurix Therapeutics to Participate in the Oppenheim... Source: N/A Jan 28, 2025 @ 9:00 PM Nurix Therapeutics Reports Fourth Quarter and Fisc... Source: Nurix Therapeutics, Inc. Nov 20, 2024 @ 9:00 PM Nurix Therapeutics Receives PRIME Designation from... Source: N/A Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.9 $-.67 $-.71 Diluted EPS $-2.9 $-.67 $-.71 Revenue $ 56.42M $ 12.59M $ 12.09M Gross Profit $ $ $ Net Income / Loss $ -176.98M $ -48.96M $ -44.55M Operating Income / Loss $ -193.7M $ -54.61M $ -48.54M Cost of Revenue $ $ $ Net Cash Flow $ 56.74M $ -17.75M $ 66.98M PE Ratio